Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors for targeted cancer therapies. Its perfluorinated aromatic group enhances binding affinity and metabolic stability in drug candidates. The compound's structure allows for efficient coupling reactions in medicinal chemistry, making it valuable in creating analogs for structure-activity relationship (SAR) studies. It is also employed in bioconjugation strategies due to the reactivity of the perfluorophenyl ester group toward nucleophiles like amines, enabling labeling of peptides and proteins in biochemical research.